Arcturus Therapeutics (NASDAQ:ARCT – Get Rating) and NightHawk Biosciences (NYSE:NHWK – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends. Valuation and Earnings This table compares Arcturus Therapeutics and […]
Wall Street analysts expect that NightHawk Biosciences (NYSE:NHWK – Get Rating) will announce sales of $1.20 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for NightHawk Biosciences’ earnings, with estimates ranging from $100,000.00 to $2.30 million. NightHawk Biosciences posted sales of $460,000.00 in the same quarter last year, […]
Brokerages forecast that NightHawk Biosciences (NYSE:NHWK – Get Rating) will announce ($0.38) earnings per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for NightHawk Biosciences’ earnings. The highest EPS estimate is ($0.33) and the lowest is ($0.42). NightHawk Biosciences reported earnings per share of ($0.26) in the same quarter last […]